Mohamad A. Hussein

Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

Lee S. Rosen, David Gordon, Mary Kaminski et al. · Cancer · 2003 · 875 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

Eric D. Hsi, Roxanne Steinle, Balaji Balasa et al. · Clinical Cancer Research · 2008 · 560 citations · Full text

Medicine, Cell Biology, Oncology +15

Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997

Ian W. Flinn, Donna Neuberg, Michael R. Grever et al. · Journal of Clinical Oncology · 2007 · 402 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Thalidomide Plus Dexamethasone Compared With Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myeloma

S. Vincent Rajkumar, Laura Rosiñol, Mohamad A. Hussein et al. · Journal of Clinical Oncology · 2008 · 345 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.

Isidore Tepler, Laurence Elias, John W. Smith et al. · PubMed · 1996 · 305 citations

Medicine, Hematology, Oncology +8